Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

149.80
Data as of Apr 17
 +0.75 / +0.50%
Today’s Change
87.01
Today|||52-Week Range
185.43
+12.73%
Year-to-Date

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Alexion Pharmaceuticals Inc have a median target of 193.50, with a high estimate of 222.00 and a low estimate of 156.00. The median estimate represents a +29.17% increase from the last price of 149.80.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Buy stock in Alexion Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.28
Sales
$538.5M
Reporting Date
Apr 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 47.10%
 
 
 
 
 
 
Growthannually 46.52%
 
 
 
 
 
 

Sales

Growthquarterly 21.86%
 
 
 
 
 
 
Growthannually 38.02%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.